Gexval is a healthcare company that helps patients and families fighting against orphan and intractable diseases.
Gexval has raised $1.9M in total funding. The most recent round was Series C. The last funding was announced in January 2025.
Gexval's investors include Mitsubishi UFJ Capital, SMBC Venture Capital, Takeda, Oita Venture Capital, Yokohama Capital.
Gexval is headquartered in Fujisawa, Japan.
Gexval is a healthcare company that helps patients and families fighting against orphan and intractable diseases.
Gexval is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gexval — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/gexval. Accessed July 20, 2026.
VCBacked. (2025). Gexval — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/gexval
{{cite web |title=Gexval — Funding & Investors |url=https://www.vcbacked.co/company/gexval |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated